IGNITE R61/R33 — Assay Development & Neurotherapeutic Screening (No Clinical Trials)
This NINDS IGNITE R61/R33 funding opportunity supports development, optimization, and validation of in vitro/ex vivo/non-mammalian assays and subsequent multi-tier screening to identify small-molecule or biologic neurotherapeutic hits (clinical trials are not allowed). The R61 phase funds feasibility and assay validation, and progression to the R33 for screening and hit characterization requir…
Source
Award
Dates
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
Get the full picture on this opportunity
Create a free Scout account to unlock everything you need to decide fast and win the grant.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Deep agency & funder detail
Program context, sub-agency structure, and a full eligibility breakdown.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Similar opportunities
Discover related funding matched to your work.
Already have an account? Sign In
Trusted by 500+ Happy Customers